The current valuation score of Sunshine Biopharma Inc is 9.86, ranking 2 out of 157 in the Pharmaceuticals industry. Its current P/E ratio is -1.63, which is -118.76% below the recent high of 0.31 and -29.75% above the recent low of -2.12.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.